Molecular Pathogenetics of Renal Cancer

1 July 2006

journal article
review article
Published by S. Karger AG in American Journal of Nephrology

Vol. 26 (3) , 218-231
https://doi.org/10.1159/000093631

Abstract

Recent developments in genetics and molecular biology have led to an increased understanding of the pathobiology of renal cancer. Thorough knowledge of the molecular pathways associated with renal cancer is a prerequisite for novel potential therapeutic interventions. Studies are ongoing to evaluate novel anticancer agents that target specific molecular entities. This article reviews current knowledge on the genetics and molecular pathogenesis of sporadic and inherited forms of renal cancer.

Keywords

This publication has 100 references indexed in Scilit:

Identification of membrane type-1 matrix metalloproteinase as a target of hypoxia-inducible factor-2α in von Hippel–Lindau renal cell carcinoma
Oncogene, 2004
Transformation capacities of the papillary renal cell carcinoma-associated PRCCTFE3 and TFE3PRCC fusion genes
Oncogene, 2001
Nuclear localization and transactivating capacities of the papillary renal cell carcinoma-associated TFE3 and PRCC (fusion) proteins
Oncogene, 2000
An Important von Hippel-Lindau Tumor Suppressor Domain Mediates Sp1-Binding and Self-Association
Biochemical and Biophysical Research Communications, 1999
Alternate choice of initiation codon produces a biologically active product of the von Hippel Lindau gene with tumor suppressor activity
Oncogene, 1999
Involvement of multiple loci on chromosome 3 in renal cell cancer development
Genes, Chromosomes and Cancer, 1997
Mutations in the ras protooncogenes are rare events in renal cell cancer
European Journal Of Cancer, 1992
The human met oncogene is related to the tyrosine kinase oncogenes
Nature, 1985
Hereditary Renal-Cell Carcinoma Associated with a Chromosomal Translocation
New England Journal of Medicine, 1979
Mutation and Cancer: Statistical Study of Retinoblastoma
Proceedings of the National Academy of Sciences, 1971